Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated earnings guidance for the fiscal year ending December 31, 2022. For the year, the company expects revenue of JPY 7 million, operating loss of JPY 2,000 million, net loss of JPY 2,000 million and basic loss per share of JPY 43.61.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68 JPY | -2.86% | -1.45% | -15.00% |
1st Jan change | Capi. | |
---|---|---|
-15.00% | 25.24M | |
+37.78% | 723B | |
+31.18% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.36% | 244B | |
-4.46% | 208B | |
+9.93% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022